Medipharm Labs Corp Stock Probability of Future OTC Stock Price Finishing Under 0.048
| MEDIF Stock | USD 0.05 0 2.22% |
Medipharm |
Medipharm Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medipharm Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medipharm Labs Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medipharm Labs Corp generated a negative expected return over the last 90 days | |
| Medipharm Labs Corp has some characteristics of a very speculative penny stock | |
| Medipharm Labs Corp has high historical volatility and very poor performance | |
| The company reported the revenue of 21.71 M. Net Loss for the year was (54.8 M) with loss before overhead, payroll, taxes, and interest of (13.42 M). | |
| Medipharm Labs Corp has accumulated about 21.99 M in cash with (13.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Medipharm Labs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medipharm OTC Stock often depends not only on the future outlook of the current and potential Medipharm Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medipharm Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 273.5 M |
Medipharm Labs Technical Analysis
Medipharm Labs' future price can be derived by breaking down and analyzing its technical indicators over time. Medipharm OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medipharm Labs Corp. In general, you should focus on analyzing Medipharm OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Medipharm Labs Predictive Forecast Models
Medipharm Labs' time-series forecasting models is one of many Medipharm Labs' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medipharm Labs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Medipharm Labs Corp
Checking the ongoing alerts about Medipharm Labs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medipharm Labs Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medipharm Labs Corp generated a negative expected return over the last 90 days | |
| Medipharm Labs Corp has some characteristics of a very speculative penny stock | |
| Medipharm Labs Corp has high historical volatility and very poor performance | |
| The company reported the revenue of 21.71 M. Net Loss for the year was (54.8 M) with loss before overhead, payroll, taxes, and interest of (13.42 M). | |
| Medipharm Labs Corp has accumulated about 21.99 M in cash with (13.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.